NYSE:IVCRQ Invacare (IVCRQ) Stock Forecast, Price & News $0.01 0.00 (-6.90%) (As of 05/5/2023) Add Compare Share Share Today's Range$0.0129▼$0.015050-Day Range$0.01▼$0.0252-Week Range$0.01▼$1.64Volume106,300 shsAverage Volume48,730 shsMarket Capitalization$512,865.00P/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsSocial MediaProfileChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsSocial Media About Invacare (NYSE:IVCRQ) StockInvacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.Read More Receive IVCRQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invacare and its competitors with MarketBeat's FREE daily newsletter. Email Address IVCRQ Stock News HeadlinesMay 27, 2023 | americanbankingnews.comInvacare (NYSE:IVCRQ) vs. Shandong Weigao Group Medical Polymer (OTCMKTS:SHWGF) Head to Head AnalysisMay 12, 2023 | americanbankingnews.comComparing LogicMark (NASDAQ:LGMK) & Invacare (NYSE:IVCRQ)June 1, 2023 | Legacy Research (Affiliate) (Ad)Sell Every Stock, Except ONE (Ticker Revealed)We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.April 21, 2023 | americanbankingnews.comCritical Contrast: Invacare (NYSE:IVCRQ) versus Coloplast A/S (OTCMKTS:CLPBY)April 1, 2023 | americanbankingnews.comFinancial Review: Invacare (IVCRQ) vs. Its CompetitorsMarch 31, 2023 | americanbankingnews.comInvacare (IVCRQ) and Its Competitors Head to Head ComparisonMarch 31, 2023 | americanbankingnews.comInvacare (IVCRQ) and Its Competitors Critical AnalysisMarch 27, 2023 | americanbankingnews.comInvacare (IVCRQ) & Its Competitors Critical ReviewJune 1, 2023 | Behind the Markets (Ad)BREAKING: The truth about war with ChinaForeign Affairs reports, "China is Now in a Prewar Tempo of Political and Military Preparations." China has one goal: take control of Taiwan, and an invasion could happen any day. I've identified 5 investments I believe are in immediate danger. But you can get out of them now - before it's too late.March 26, 2023 | americanbankingnews.comInvacare (IVCRQ) and The Competition Financial ReviewMarch 26, 2023 | americanbankingnews.comAvanos Medical (NYSE:AVNS) vs. Invacare (NYSE:IVCRQ) Head to Head ContrastMarch 23, 2023 | americanbankingnews.comAnalyzing Invacare (IVCRQ) and Its RivalsMarch 23, 2023 | americanbankingnews.comContrasting Invacare (IVCRQ) and Its PeersSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive IVCRQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invacare and its competitors with MarketBeat's FREE daily newsletter. Email Address IVCRQ Company Calendar Today6/01/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNYSE:IVCRQ CUSIPN/A CIK742112 WebN/A Phone(440) 329-6000Fax877-619-7996Employees2,800Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-101,070,000.00 Net Margins-16.72% Pretax Margin-16.33% Return on Equity-94.34% Return on Assets-10.81% Debt Debt-to-Equity Ratio4.25 Current Ratio1.46 Quick Ratio0.93 Sales & Book Value Annual Sales$741.73 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$1.21 per share Price / Book0.01Miscellaneous Outstanding Shares37,990,000Free Float35,365,000Market Cap$512,865.00 OptionableOptionable Beta0.50 Key ExecutivesGeoffrey P. PurtillPresident, Chief Executive Officer & DirectorKathleen Patricia LeneghanSenior VP, Chief Financial & Accounting OfficerAngie GoodwinSVP, Chief Technology & Information OfficerJoost BeltmanSenior VP & General Manager-North AmericaAnthony C. LaPlacaSecretary, Chief Administrative Officer & SVPKey CompetitorsTricidaNASDAQ:TCDAQViveve MedicalNASDAQ:VIVEChina SXT PharmaceuticalsNASDAQ:SXTCCodiak BioSciencesNASDAQ:CDAKPear TherapeuticsNASDAQ:PEARView All Competitors IVCRQ Stock - Frequently Asked Questions How have IVCRQ shares performed in 2023? Invacare's stock was trading at $0.04 at the start of the year. Since then, IVCRQ shares have decreased by 66.3% and is now trading at $0.0135. View the best growth stocks for 2023 here. What is Invacare's stock symbol? Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVCRQ." How do I buy shares of Invacare? Shares of IVCRQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Invacare's stock price today? One share of IVCRQ stock can currently be purchased for approximately $0.01. How much money does Invacare make? Invacare (NYSE:IVCRQ) has a market capitalization of $512,865.00 and generates $741.73 million in revenue each year. How many employees does Invacare have? The company employs 2,800 workers across the globe. How can I contact Invacare? Invacare's mailing address is PO Box 4028, Elyria, Ohio 44036-2028. The company can be reached via phone at (440) 329-6000, via email at loislee@invacare.com, or via fax at 877-619-7996. This page (NYSE:IVCRQ) was last updated on 6/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invacare Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.